In 218 patients with large-vessel-occlusion stroke due for thrombectomy, tenecteplase 0.25 mg/kg gave substantial reperfusion on initial angiogram in 10.3% vs 3.6% with alteplase 0.6 mg/kg, meeting superiority; 90-day function, bleeding and mortality were similar.
RCTn = 218
Inoue et al. Standard-Dose Tenecteplase vs Low-Dose Alteplase for Acute Ischemic Stroke From Large-Vessel Occlusion: A Randomized Clinical Trial